glp-1 dual agonist Cardiorenal Outcomes With vs. GLP-1/GIP Agonists 🔴Comparison of GLP-1R Mono-Agonist vs.

doi: 10.1126/science.aac4854

BPC-157 accelerates healing by stimulating angiogenesis and cellular proliferation, while GHK-Cu supports tissue regeneration through collagen production and extracellular matrix remodeling

Histopathology According to the guidelines of Carson et al

Male SpragueDawley rats were divided into three experimental groups, with diabetic rats in Groups 2 and 3

Thus, the decreased cardiorenal risk associated with the combined use of GLP1-RAs/SGLTis may be attributed to an additive effect, achieved by the distinct mechanisms and sites of action for these different drug classes [13]

For anyone whos been through muscle damage, this is a game-changer